SCHEMBL27186117

SCHEMBL27186117

O=c1c2cn[nH]c2ccn1[C@H]1CC[C@@H](C(=O)O)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 3/20 0.38
▸ PIM1 P11309 3/20 0.38
▸ PIK3CA P42336 3/20 0.38
▸ GSK3B P49841 3/20 0.38
▸ PIK3CG P48736 2/20 0.38
▸ TNKS O95271 1/20 0.36
▸ PIK3CB P42338 2/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ FLT3 P36888 1/20 0.35
▸ CCNA1 P78396 1/20 0.35
▸ PRKAG1 P54619 1/20 0.35
▸ PRKAA1 Q13131 1/20 0.35
▸ PRKAB1 Q9Y478 1/20 0.35
▸ TRPV1 Q8NER1 5/20 0.34
▸ MAP4K1 Q92918 4/20 0.33
▸ ABL1 P00519 2/20 0.33
▸ DUSP3 P51452 1/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ ARHGDIA P52565 1/20 0.33
▸ ROCK1 Q13464 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27186122 1.00 PIK3CD (0.38) PIK3CDPIM1PIK3CAGSK3BPIK3CG
Hydrochloric Acid SCHEMBL28431833 0.88 METAP2 (0.36) TNKSTRPV1ROCK2ARHGDIAROCK1
SCHEMBL29168362 0.85 MAP4K1 (0.38) PIK3CDPIM1PIK3CAGSK3BPIK3CG
SCHEMBL27186139 0.80 HCAR1 (0.39) PIK3CDPIK3CAGSK3BPIK3CGPIK3CB
SCHEMBL27186487 0.75 JAK1 (0.43) PIK3CDPIK3CACDK2MAP4K1
SCHEMBL27186077 0.75 MAP4K1 (0.32) MAP4K1
SCHEMBL14158155 0.70 ALDH1A1 (0.37) PRKAG1PRKAA1PRKAB1DUSP3MEN1
SCHEMBL14158157 0.70 ALDH1A1 (0.37) PRKAG1PRKAA1PRKAB1DUSP3MEN1
SCHEMBL27186133 0.67 DUSP3 (0.44) DUSP3MEN1KMT2A
SCHEMBL27186129 0.67 DUSP3 (0.44) DUSP3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109887-A1 NOVEL SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AS SOS1 INHIBITORS VIVA STAR BIOSCIENCES (SUZHOU) CO., LTD. (CN) 2024-04-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109887-A1 NOVEL SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AS SOS1 INHIBITORS SOS1, SOS2, KSR1 PIK3CD 433/4885PIM1 1508/4885PIK3CA 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback